2025-2034 Influenza Diagnostic Market Outlook: Key Drivers, Emerging Challenges, and Strategic Insights

Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Will the Influenza Diagnostic Industry Market Size Be by 2025?
Expansion within the influenza diagnostic sector has been consistent over the previous years, projected to increase from a valuation of $2.73 billion in 2024 to $2.87 billion in 2025, reflecting a compound annual growth rate of 4.9%; this upward trajectory during the historical phase is traceable to the burgeoning e-commerce domain, constraints in the available workforce, advancements in automation leading to higher productivity, refinements in supply chains, escalating expenses related to labor, and official backing for robotics and automation initiatives.

What's the Long-Term Growth Forecast for the Influenza Diagnostic Market Size Through 2029?
Anticipating robust expansion, the market for influenza diagnostics is set for significant escalation, projecting a valuation of $3.9 billion by 2029, fueled by an 8.0% compound annual growth rate throughout this projected timeframe. This upward trajectory is fundamentally driven by requirements for enhanced customization and scalable solutions, alignment with ecological and sustainability targets, the imperative to boost operational throughput, and the necessity to effectively navigate the complexities inherent in contemporary supply chain structures. Key developments shaping the market across this forecast window encompass the incorporation of sophisticated technological tools, the increased utilization of automated systems for picking and packing processes, the deployment of self-governing mobile robotic units, the adoption of immediate data access and analytical insights, the implementation of artificial intelligence for informed choices, the use of collaborative robotic devices, and continuous innovation within robotic engineering itself.

View the full report here:
https://www.thebusinessresearchcompany.com/report/influenza-diagnostic-global-market-report

What Are the Key Growth Drivers Fueling the Influenza Diagnostic Market Expansion?
It is anticipated that the advancements in rapid diagnostic testing methodologies will serve as a significant catalyst for the forward progression of the influenza diagnostic marketplace.Medical assessments, which are procedures or instruments employed to definitively establish or exclude the presence of an ailment or sickness, are categorized as diagnostic tests.The utilization of rapid diagnostic tests (RDTs) is on the rise, driven by the healthcare sector's escalating requirement for outcomes that are both swift and precise.Specifically, rapid influenza diagnostic tests (RIDTs) possess the capability to identify influenza viral antigens within a brief 10 to 15-minute window, offering a moderate level of sensitivity ranging between 50 and 70 percent.To illustrate this trend, data from the Australian Institute of Health and Welfare, a governmental entity in Australia responsible for health and disease information, indicated an increase in the total number of diagnostic imaging services from 28.4 million during the 2021-22 period to 29.7 million across 2022-23.Consequently, the impetus provided by these rapid diagnostic tests is directly influencing the advancement trajectory of the influenza diagnostic sector.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3237&type=smp

What Are the Key Trends Driving Influenza Diagnostic Market Growth?
Leading firms within the influenza diagnostics sector are focused on engineering novel solutions, exemplified by the Lucira COVID-19 & Flu Home Test, engineered for the concurrent rapid, qualitative identification of multiple pathogens. This specific examination kit, the Lucira COVID-19 and Flu Home Test, functions as a disposable unit requiring self-collection of nasal swab specimens, yielding outcomes in approximately half an hour. As a concrete illustration, Pfizer Inc., a pharmaceutical entity headquartered in the United States, secured authorization for this Lucira COVID-19 & Flu Home Test in February of 2023. The capability of this diagnostic tool extends to identifying both Influenza A and B strains, which are generally recognized as the flu, alongside SARS-CoV-2, the agent responsible for the COVID-19 illness.

How Is the Influenza Diagnostic Market Segmented?
The influenza diagnosticmarket covered in this report is segmented -

1) By Traditional diagnostic tests: Rapid influenza diagnostic tests (RIDT); Viral Culture; DFA; Serological assays; Other Traditional diagnostic tests
2) By Molecular diagnostic tests: Reverse Transcription Polymerase Chain Reaction (RT-PCR); Isothermal Nucleic Acid Amplification Tests (INAAT); Loop Mediated Isothermal Based Amplification Assays; Transcription Mediated Isothermal Based Amplification Assays; Transcription Mediated Isothermal Based Amplification Assays; Other Isothermal Nucleic Acid Amplification Tests; Other Molecular Diagnostic Tests
3) By End User: Hospitals And Clinical Laboratories; Diagnostic Reference Laboratories; Academic/Research Institutes; Other End Users

Subsegments:
1) By Rapid Influenza Diagnostic Tests (RIDT): Immunoassay-based Tests; Lateral Flow Assays; Enzyme Immunoassays (EIA)
2) By Viral Culture: Cell Culture; Egg-based Culture
3) By Direct Fluorescent Antibody (DFA) Test: Direct Fluorescent Antibody Staining
4) By Serological Assays: Hemagglutination Inhibition (HI) Assay; Enzyme-Linked Immunosorbent Assay (ELISA); Western Blotting Assay
5) By Other Traditional Diagnostic Tests: Polymerase Chain Reaction (PCR); Immunofluorescence Assays

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=3237&type=smp

Which Companies Are Leading the Charge in Influenza Diagnostic Market Innovation?
Major companies operating in the influenza diagnostic market include F. Hoffmann-La Roche Ltd., Quidel Corporation, Thermo Fisher Scientific Inc., Abbott Laboratories, Hologic Inc., Becton dic*kinson and Company, DiaSorin SpA, Luminex Corporation, Meridian Bioscience Inc., GenMark Diagnostics Inc., SA Scientific Ltd., Sekisui Diagnostics LLC, bioMérieux Inc., Danaher Corporation, Siemens Healthineers AG, Coris Bioconcept Sprl, Mast Group, Elitech Technology lnc., Analytik Jena AG, altona Diagnostics GmbH, Tecan Trading AG, Genome Diagnostics Pvt Ltd., Germaine Laboratories Inc., Response Biomedical Corporation, TAUNS Laboratories Inc., TRUPCR Europe Ltd., Quest Diagnostics Inc., Labcorp Employer Services Inc., TotalWellness Ltd., Health Advocate Inc., Optum Global Solutions Private Ltd.

Which Regions Are Leading the Global Influenza Diagnostic Market in Revenue?
North America was the largest region in the influenza diagnostics market in 2024. Western Europe was the second largest region in the influenza diagnostics market. The regions covered in the influenza diagnostic market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3237

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.